n this issue:
Risk of stroke and TIA in patients with resolved AF
Subcutaneous fremanezumab for migraine
Amyloid and tau accumulation in AD carriers
Cost-effectiveness of preventive ceftriaxone in acute stroke
Teratogenic risk of antiepileptic drugs
Escitalopram in patients with cervical dystonia
Intensive aphasia therapy in patients with chronic stroke
Impact of anaesthesia and surgery on biomarkers of neurological injury
Genetic variants in titin in patients with muscle disorders
Risk of intracranial haemorrhage in anticoagulated AF patients
Please login below to download this issue (PDF)